• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MYX

MAYNE PHARMA GROUP LIMITED - Charts / Financials

1.18% ! $5.13
Market Cap $416.7M  !
Healthcare Drug Manufacturers - Specialty & Generic
Add to My Watchlist

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 21/08/2025 (20 minute delay) ?
Day
Open $5.08   Day High $5.20   Day Low $5.06
Daily Volume 116092
Bids   Sellers
Number Price Volume   Number Price Volume
1 $5.08 4724   2 $5.13 480

Directors & Senior Management

Mr. Shawn Patrick O' Brien Chief Executive Officer, Managing Director, Executive Director
Mr. Aaron Gray Chief Financial Officer
Ms. Laura Loftus Company Secretary
Mr. Frank C. Condella Non-Executive Independent Chairman of the Board
Mr. David Petrie Non-Executive Director
Mr. Patrick J. Blake Independent Non-Executive Director
Ms. Ann Custin Independent Non-Executive Director
Ms. Anne Nicole Lockwood Independent Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$5.13 		Change
0.060(1.18%) 		Mkt cap ! $416.7M
Open High Low Value Volume
$5.08 $5.20 $5.06 $598.3K 116.0K

Buyers (Bids)

No. Vol. Price($)
1 4724 $5.08
 

Sellers (Offers)

Price($) Vol. No.
$5.13 480 2
View Market Depth
Last trade - 16.18pm 21/08/2025 (20 minute delay) ?
Last
$5.13 		  Change
0.060 ( 0.32 %)
Open High Low Volume
$5.08 $5.19 $5.06 19493
Last updated 15.59pm 21/08/2025 ?

Top Stories

Vault Minerals CEO to exit – and investors don't seem at all bothered

Vault Minerals has rocketed after dropping news that the company's managing director and CEO, Luke Tonkin, will be stepping down.
More malaise for Melbana as latest Cuban drilling plans fail to excite Melbana Energy failed to rouse excitement even after its fresh pending drill run hunting for oil in the niche jurisdiction of Cuba.
Listen: HotCopper Wire Podcast 021 – The inexplicable Kaili Resources rocket This week in the HotCopper Wire podcast we talk ASX earnings season, the +8,700% Kaili Resources rocket from Monday, and plenty more.
Neurizon NUZ-001 OLE study demonstrates long-term safety, efficacy signals HotCopper sat down with Neurizon Therapeutics MD Michael Thurn to discuss the clinical-stage biotech company's latest NUZ-001 OLE study.
ASX Market Close: Index cracks 9,000pts and all-time high The ASX 200 has smashed through the big 9,000 mark for the first time ever, hitting a fresh all-time high of 9,013 in intraday trade.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.